F7553
FR 122047 hydrochloride
≥98% (HPLC), powder
別名:
1-[(4,5-Bis(4-methoxyphenyl)-2-thiazoyl)carbonyl]-4-methylpiperazine hydrochloride
サイズを選択してください
| サイズ/SKU | 在庫状況 | 単価 |
|---|---|---|
25 mg | カートの在庫状況を確認する | ￥114,000 |
この商品について
￥114,000
biological source
synthetic (organic)
Quality Segment
assay
≥98% (HPLC)
form
powder
color
faintly yellow
solubility
methylene chloride: 50 mg/mL, slightly hazy, yellow
shipped in
wet ice
storage temp.
2-8°C
SMILES string
Cl[H].COc1ccc(cc1)-c2nc(sc2-c3ccc(OC)cc3)C(=O)N4CCN(C)CC4
InChI
1S/C23H25N3O3S.ClH/c1-25-12-14-26(15-13-25)23(27)22-24-20(16-4-8-18(28-2)9-5-16)21(30-22)17-6-10-19(29-3)11-7-17;/h4-11H,12-15H2,1-3H3;1H
InChI key
YWMAVHIKOAOSFM-UHFFFAOYSA-N
Biochem/physiol Actions
1 of 1
当該品目 | |||
|---|---|---|---|
| description ≥98% (HPLC), powder | description The COX-1 Inhibitor, FR122047, also referenced under CAS 130717-51-0, controls the biological activity of COX-1. This small molecule/inhibitor is primarily used for Cell Signaling applications. | description A cell-permeable, non-steroidal anti-inflammatory drug (NSAID) of the oxicam family which preferentially inhibits the inducible isoform of COX-2 (IC50 = 4.7 µM) relative to COX-1 (IC50 = 36.6 µM). | description solid |
| biological source synthetic (organic) | biological source - | biological source - | biological source - |
| assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay - |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| form powder | form solid | form solid | form solid |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. - |
| shipped in wet ice | shipped in ambient | shipped in ambient | shipped in - |
保管分類
11 - Combustible Solids
WGK
WGK 3
引火点 (F)
Not applicable
引火点（°C）
Not applicable
PPE（個人用保護具）
Eyeshields, Gloves, type N95 (US)